Proto Labs Inc. Announces New Consulting Agreement with Former CEO Dr. Bodor, Offering $5,000 Monthly Fee

Reuters
31 May
<a href="https://laohu8.com/S/PRLB">Proto Labs Inc</a>. Announces New Consulting Agreement with Former CEO Dr. Bodor, Offering $5,000 Monthly Fee

Proto Labs Inc. has announced a new consulting agreement with former President and CEO, Dr. Robert Bodor, following his departure from the company on May 20, 2025. Under the terms of the agreement, Dr. Bodor will provide transitional consulting services in exchange for a monthly fee of $5,000. The agreement, effective from May 28, 2025, will continue until November 11, 2025, contingent on Dr. Bodor signing a general waiver and release of claims. Additionally, Dr. Bodor is entitled to retain his vested stock options under the company's 2022 Long-Term Incentive Plan, which he can exercise as per the plan's terms until the termination or expiration of the consulting agreement. Any unexercised options will remain exercisable for three months post-termination.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Proto Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-054901), on May 30, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10